ACM Research reports 65% YoY order growth in Q1 2026 amid SPM tool advancement
ACM Research (Shanghai) reported 65% year-over-year growth in newly signed orders during Q1 2026, with management highlighting progress in high-temperature single-wafer plasma source ion implantation tools achieving 15nm particle control. The company maintained its 2026 revenue guidance unchanged, citing typical 6-month delivery cycles and customer acceptance requirements.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day